145 related articles for article (PubMed ID: 1532243)
1. Oncogenic activation of murine mos protein kinase by DNA rearrangement of its N-terminal coding region.
Ohuchi T; Kurita Y; Sasai H; Miyoshi J; Nomura T; Toyoshima K
Oncogene; 1992 Feb; 7(2):331-8. PubMed ID: 1532243
[TBL] [Abstract][Full Text] [Related]
2. Activation of c-mos oncogene by integration of an endogenous long terminal repeat element during transfection of genomic DNA from mouse skin tumor cells.
Wang S; Nishigori C; Miyakoshi J; Tsukada T; Shung B; Yagi T; Takebe H
Oncogene; 1993 Apr; 8(4):1009-16. PubMed ID: 8455928
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
Albor A; Thraves PJ; Dritschilo A; Notario V
Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
[TBL] [Abstract][Full Text] [Related]
4. Characterization of activated and normal mouse Mos gene in murine 3T3 cells.
Paules RS; Resnick J; Kasenally AB; Ernst MK; Donovan P; Vande Woude GF
Oncogene; 1992 Dec; 7(12):2489-98. PubMed ID: 1461652
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of transforming variants of the lck tyrosine protein kinase.
Adler HT; Sefton BM
Oncogene; 1992 Jun; 7(6):1191-9. PubMed ID: 1594248
[TBL] [Abstract][Full Text] [Related]
6. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
Velasco JA; Avila MA; Notario V
Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
[TBL] [Abstract][Full Text] [Related]
7. Evidence for somatic cell expression of the c-mos protein [corrected].
Herzog NK; Ramagli LS; Khorana S; Arlinghaus RB
Oncogene; 1989 Nov; 4(11):1307-15. PubMed ID: 2530484
[TBL] [Abstract][Full Text] [Related]
8. A mechanism of c-raf-1 activation: fusion of the lipocortin II amino-terminal sequence with the c-raf-1 kinase domain.
Mitsunobu F; Fukui M; Oda T; Yamamoto T; Toyoshima K
Oncogene; 1989 Apr; 4(4):437-42. PubMed ID: 2524024
[TBL] [Abstract][Full Text] [Related]
9. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
[TBL] [Abstract][Full Text] [Related]
10. Transforming activity of the RL-akt gene, a c-akt gene activated by long terminal repeat insertion in murine leukemia RL(male symbol)1 cells.
Tanino M; Matsuo M; Uenaka A; Tsukuda K; Ouchida M; Nakayama E; Shimizu K
Mol Carcinog; 1999 Dec; 26(4):286-97. PubMed ID: 10569805
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic analysis of functional domains of the mos proto-oncogene and identification of the sites important for MAPK activation and DNA binding.
Fukasawa K; Zhou R; Matten WT; Armstrong AJ; Daar I; Oskarsson M; Sathyanarayana BK; Maclvor L; Wood TG; Vande Woude GF
Oncogene; 1995 Oct; 11(8):1447-57. PubMed ID: 7478569
[TBL] [Abstract][Full Text] [Related]
12. Human hst-2 (FGF-6) oncogene: cDNA cloning and characterization.
Iida S; Yoshida T; Naito K; Sakamoto H; Katoh O; Hirohashi S; Sato T; Onda M; Sugimura T; Terada M
Oncogene; 1992 Feb; 7(2):303-9. PubMed ID: 1549352
[TBL] [Abstract][Full Text] [Related]
13. The human met oncogene is a member of the tyrosine kinase family.
Gonzatti-Haces M; Park M; Dean M; Blair DG; Vande Woude GF
Princess Takamatsu Symp; 1986; 17():221-32. PubMed ID: 3332011
[TBL] [Abstract][Full Text] [Related]
14. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
Lansing TJ; Turk BF; Kanner SB; Gilmer TM
Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
[TBL] [Abstract][Full Text] [Related]
15. cph, a novel oncogene which cooperates with H-ras in the transformation of NIH3T3 fibroblasts.
Velasco JA; Castro R; Avila MA; Laborda J; DiPaolo JA; Cansado J; Notario V
Oncogene; 1994 Jul; 9(7):2065-9. PubMed ID: 8208552
[TBL] [Abstract][Full Text] [Related]
16. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
[TBL] [Abstract][Full Text] [Related]
17. Integration of proviral DNA into the PDGF beta-receptor gene in HTLV-I-infected T-cells results in a novel tyrosine kinase product with transforming activity.
Chi KD; McPhee RA; Wagner AS; Dietz JJ; Pantazis P; Goustin AS
Oncogene; 1997 Aug; 15(9):1051-7. PubMed ID: 9285559
[TBL] [Abstract][Full Text] [Related]
18. N-myc activation by proviral insertion in MCF 247-induced murine T-cell lymphomas.
Dolcetti R; Rizzo S; Viel A; Maestro R; De Re V; Feriotto G; Boiocchi M
Oncogene; 1989 Aug; 4(8):1009-14. PubMed ID: 2548143
[TBL] [Abstract][Full Text] [Related]
19. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
[TBL] [Abstract][Full Text] [Related]
20. Analysis of structure and activation of some receptor-type tyrosine kinase oncogenes.
Shibuya M; Matsushime H; Yamazaki H; Wang LH; Fukui Y; Ueyama Y; Tamaoki N
Princess Takamatsu Symp; 1986; 17():195-202. PubMed ID: 3455414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
